Integral labels $356m bid ‘a minor distraction’
SYDNEY: Takeover target Integral Diagnostics has labelled a $356 million hostile takeover from smaller rival
SYDNEY: Takeover target Integral Diagnostics has labelled a $356 million hostile takeover from smaller rival
FEATURED
Innovative volunteer programs enhance well being in senior living communities
First dementia drug now set to go on trial
Developer to target luxury apartment market for downsizers
Apartment complex for cancer patients and their families open
Group behind ‘suicide pod’ suspends use after woman’s death
Improving staff quality top challenges in senior living say clinical leaders
INNOVATION
